Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...
The recommendation is included in the organization’s “Guidelines for the management of chronic coronary syndromes,” published Aug. 30 in the European Heart Journal. “Ultrasound contrast agents ...
Transthoracic echocardiography, the most common type of echocardiogram, uses a transducer on a person’s chest to send high frequency ultrasound waves through the chest wall to the heart to create ...
N. BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
ST. LOUIS – A Saint Louis University cardiologist called upon the U.S. Food and Drug Administration (FDA) today to reconsider a strong warning it recently placed on a diagnostic tool, stating that the ...
The Food and Drug Administration (FDA) has approved Lumason (sulfur hexafluoride lipid-type A microspheres; Bracco Diagnostics Inc.), an ultrasound enhancing agent, for use in echocardiography to ...
CHICAGO--(BUSINESS WIRE)--Sonographers trained in administering ultrasound enhancing agents (UEAs) can help improve patient care while also reducing health care costs, a Harvard cardiologist said ...
A 42-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) was referred for alcohol septal ablation (ASA). She had been diagnosed with HCM 20 years earlier following presentation with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results